Strength is how much nicotine reaches you; burn is irritation your nerves report. They are measured separately, and they move together only weakly. A higher-nicotine pouch does rate harsher — by about seven points on a hundred-point scale in the one randomised test. But in a clinical crossover, plasma nicotine climbed from nothing to 7.1 ng/mL with no change in rated mouth irritation at all.
Almost everyone who starts with pouches or snus does the same thing: reaches for a stronger tin because the first one did not sting enough, or backs off a brand because the sting was unpleasant and assumes the dose was too high. Both moves treat one sensation as a readout of the other. The research says that is only a little bit true, and that most of what you feel on your gum is set by things other than the milligram figure.
This page is about telling the two apart. If you want the mechanism of the sting itself, that is why nicotine pouches tingle. If you want the specific case of mint reading as strength, that is why mint pouches feel stronger than they are. Here I am setting the two sensations side by side and asking what the evidence says about the link between them.
They are measured separately, and only one of them tracks whether you like it
The instrument researchers use on these products rates ten things on a 100 mm line, and burn and strength are different items on it. In the 2024 study that established the method, participants were asked, among other questions, “How harsh was the product?”, “How strong was the flavor of the product?”, “How much did the product tingle in your mouth?” and “How strong was the burning sensation in your mouth?” — four separate scales, not one.
That study, by Peraza and colleagues at the University of Southern California, ran Twenty-three young adults without ONP experience who use e-cigarettes completed a single-blind, single-visit remote lab study.
It was funded by the National Cancer Institute, FDA’s Center for Tobacco Products and the National Institute on Drug Abuse, and its competing-interests statement reads None declared.
No industry money.
Its most useful finding for anyone choosing a product is almost an aside: Appeal correlated with most types of sensory experiences (rs = -0.33-0.54), except for tingling and burning.
Sweetness, flavour strength, cooling, smoothness — all of those tracked how much people liked a pouch. Tingling and burning did not. The two sensations people use as a proxy for strength are the two that carry the least information about whether they will enjoy the thing.
It also found flavour, not nicotine, moving burn: Fruit-flavored ONPs were sweeter (B = 12.9, 95% CI = 6.1, 19.7) and caused less burning (B = -12.0, 95% CI = -19.5, -4.5) than mint.
Twelve points of burn difference, from the flavour alone. I would not read too much into a 23-person study, but it is the cleanest demonstration that these are separable quantities.
More nicotine does make a pouch harsher — by about seven points on a hundred
I expected to find that nobody had run this experiment. Somebody has. Han and colleagues published a double-blind, within-subject randomised study in Addiction in 2026, drawing four products at a time from a pool of twenty ZYN and on! pouches varying in nicotine strength (high: 6-8 mg vs. low: 3-4 mg) and pH (high: 8.5-9.3 vs. low: 7.6-8.0)
, across 73 participants and 292 observations.
The result:
high (vs. low) nicotine strength produced statistically significant lower ratings of appeal (b = -8.75, 95% confidence interval [CI] = -15.41, -2.08) and smoothness (b = -7.72, 95% CI = -14.01, -1.44) and higher harshness ratings (b = 7.21, 95% CI = 1.07, 13.36). No statistically significant linear effects of pH on appeal and sensory attributes were observed.
So: roughly double the nicotine buys you about seven points of extra harshness on a hundred-point scale, with flavour statistically controlled, and costs you nearly nine points of appeal. The coupling is real and it is modest. The confidence interval runs from 1.07 to 13.36, which is another way of saying the study can tell you the direction and not much about the size.
Two honest limits. These were off-the-shelf products, so nicotine and pH were not crossed by the experimenters and formulations differed in other ways; flavour was adjusted for statistically rather than held physically constant. And the funding is mixed: FDA and the National Institute on Drug Abuse paid for it, with laboratory facilities under a National Cancer Institute grant, but one author discloses a Pfizer research grant and advisory-board service for Johnson & Johnson and Kenvue outside the work.
And yet the dose can quadruple with no change in how much it stings
The German Federal Institute for Risk Assessment ran the study that pulls hardest the other way. Fifteen smokers used five products in crossover — nicotine-free, 6 mg, 20 mg and 30 mg pouches, all mint, plus their own cigarette — with blood sampling and symptom ratings over four hours. It was paid for out of the institute’s own budget: The study was funded by intermural funding from the German Federal Institute for Risk Assessment (BfR)
— the typo is theirs — with no commercial relationships declared.
| Product used for 20 minutes | Peak plasma nicotine (Cmax) | Rated mouth irritation |
|---|---|---|
| Nicotine-free pouch | no uptake | moderate |
| 6 mg pouch | 2.8 ng/mL | moderate |
| 20 mg pouch | 7.1 ng/mL | moderate |
| 30 mg pouch | 29.4 ng/mL | strong |
| Own cigarette | 15.2 ng/mL | low |
In the authors’ words: Strong mouth irritations were reported in the first 10 min of use of the 30 mg nicotine pouch
and Use of the other pouches resulted in medium mouth irritations, regardless of the nicotine strength, while cigarette smoking did not have such an effect.
Read the first three rows again. Zero to 7.1 ng/mL of plasma nicotine, and the irritation rating does not budge. The cigarette is the sharpest line in the table: more nicotine in the blood than the 20 mg pouch, and the least irritation of anything tested. Whatever burn is tracking, it is not dose.
The nicotine-free arm is the other half of the point. Consumption of nicotine-free pouches did not result in a nicotine uptake
, and it still produced moderate irritation. The authors are careful about what that means: Moderate mouth irritation was reported by the participants at the beginning of consumption of the pouches with 0, 6, and 20 mg nicotine.
and However, as the pouches with no nicotine or low amounts also induced local adverse effects, other substances are involved.
They do not say which substances, and they measured no pH — I checked the paper for it.
One thing worth knowing before anyone over-reads the word “irritation”: the examiners also looked. A slightly increased redness was revealed in 1, 4, 3, and 5 cases after use of the pouches with 0, 6, 20, and 30 mg nicotine, respectively.
One case in fifteen for the nicotine-free pouch. And An ulceration was visible in one case after use of the 6 mg pouch.
— on the weak product, not the 30 mg one. These are small numbers in a small study and I would not build anything on them, but they are the measurements, and they are a long way from “everyone”.
Nicotine only burns in the form that absorbs, which is the awkward part
There is a mechanism linking the two sensations, and it is not the one most people assume. Nicotine is itself an irritant: Talavera and colleagues found that the chemosensory cation channel transient receptor potential A1 (TRPA1) is crucially involved in nicotine-induced irritation
, reporting that We found that micromolar concentrations of nicotine activated heterologously expressed mouse and human TRPA1.
TRPA1 is the same channel mustard oil works on.
But it only does that in one chemical form. Work on isolated mouse oral mucosa put it bluntly: The hydrophilic nicotine was ineffective unless applied unprotonated in alkaline (pH9) solution, activating TRPA1 and TRPV1.
The unprotonated, free-base fraction is also precisely the form that crosses your gum. So the same variable — pH — raises the dose and arms the irritant at the same time. That is a reason to expect strength and burn to be entangled rather than separable, and it is the strongest argument against this article’s own thesis.
Which is why the Han study’s second finding matters as much as its first. In actual commercial pouches spanning pH 7.6 to 9.3, No statistically significant linear effects of pH on appeal and sensory attributes were observed.
The mechanism is real in a dish. In the mouth, across the pH range the market actually occupies, it did not show up in the harshness ratings. I would not call that settled either way. What I would say is that anyone telling you confidently that alkalinity is why your pouch stings is going beyond the evidence. For what pH demonstrably does do — which is set the dose — see pouch pH and why it changes the hit and, for snus, snus pH and why it changes the nicotine hit.
Two things you cannot see are set independently of the strength
Here is the cleanest fact in this whole area. A laboratory at the University of Southern California, Ohio State and Duke measured the synthetic coolant WS-3 in ZYN’s odourless “Chill” and “Classic” products by GC-MS and found that they and “Classic” ONPs contained WS-3 exclusively (0.24±0.02 mg/pouch), with consistent levels across nicotine strengths
, while the Smooth and Original versions contained neither menthol nor WS-3
.
Across the 3 mg and 6 mg versions, the measured nicotine roughly doubled — 2.89 mg to 5.61 mg per pouch — and the coolant did not move: 0.25 mg against 0.24 mg. The “stronger” pouch delivers exactly the same cold.
If you have ever stepped up a strength within one product line and felt the cooling stay put while something else changed, that is because it did. The cold is a formulation constant; the nicotine is the variable. They are shipped in the same tin and have nothing to do with each other.
The sweetness is scaled up with the nicotine
One more confounder, and it runs in the unhelpful direction. A 2026 analysis of sweeteners in pouches found that in Velo products, sweetened with sucralose, higher nicotine strength products contained higher sucralose levels
— the paper describes some brands adding more sweeteners to higher nicotine strength ONPs
.
So a stronger pouch from that line is also a sweeter pouch, deliberately. Sweetness is one of the dimensions that tracks appeal strongly. If you are using “this one feels different” as evidence about dose, part of what you are tasting was added to cover the dose. Our page on sweeteners in nicotine pouches goes through the figures.
Burn fades on a timescale you can actually feel; the dose does not
The two sensations also behave differently over time, and this is the best-evidenced thing in the brief. Dessirier and colleagues applied nicotine to one side of volunteers’ tongues and the vehicle to the other, then came back later: After intervals of 0.5, 1, and 24 h, a significant majority of subjects chose the vehicle-treated side as having stronger irritation
, and The effect was not present after 48 h.
Nicotine numbs the tissue to its own irritation within half an hour, and the numbing is gone two days later. That is a genuinely odd property — capsaicin does the opposite, getting worse on repeated application in the same experimental setup. It also explains a common experience without any appeal to tolerance: the second pouch of the day stings less than the first because your mouth is still partly desensitised, not because anything about your nicotine sensitivity changed.
Nothing comparable happens to absorption. Which means that over a day of use, burn and dose drift apart on their own.
Worth stating plainly: nobody has followed new pouch users through weeks of habituation. The evidence above is single applications to tongues, and it stops at 48 hours.
Strength and burn, side by side
| Strength (dose) | Burn (irritation) | |
|---|---|---|
| What it physically is | Nicotine crossing the oral mucosa into blood | TRPA1 and TRPV1 channels firing on sensory nerve endings |
| What sets most of it | Nicotine content, pH, pouch mass, hold time, and the individual user | Formulation — flavour compounds, coolants, alkali — with nicotine a minor contributor |
| Measured link to the other | Weak. About 7 points of harshness per doubling of nicotine in one randomised study; no detectable irritation change across a 0–7.1 ng/mL plasma range in another | |
| Does it track whether you like the product? | Indirectly, via appeal | No — burning and tingling were the two dimensions uncorrelated with appeal |
| Does it fade with use? | No | Yes — within 30 minutes, gone by 48 hours |
| Can you check it on the tin? | Partly: the milligram figure is content, not delivery | No. No maker publishes a coolant or irritant quantity |
If you want to move the dose, hold time is the lever you already have
The most actionable numbers come from a seven-way crossover run and funded by British American Tobacco — worth knowing, and worth using, because nobody independent has measured it:
Extracted nicotine was greater for the 11-mg than for the 20-mg NP, (10 min, 28.0% vs. 22.4%; 20 min, 35.8% vs. 29.6%; 30 min, 43.7% vs. 36.9%, respectively).
Going from ten minutes to thirty roughly halves again what is left in the pouch — extraction rises by about fifteen percentage points — and it does so without changing anything you can taste. That is the cleanest way to adjust your dose without chasing the sting. It also makes the higher-strength pouch look less impressive than its label: at every hold time, the 20 mg product gave up a smaller fraction of what was in it.
The same study settles a persistent myth: Only 1.8% of the nicotine measured in the reference NPs was detected in saliva collected over the 30 min use period.
Spitting or not spitting is close to irrelevant to the dose. The study’s conflict-of-interest statement is explicit — At the time the study was conducted, all authors were employees of BAT, which was the sponsor and funding source of this study.
For the general case of labels and delivery diverging, see nicotine delivery vs nicotine content; if you are trying to come down rather than up, how to step down your strength safely and strength creep are the pages to read next. The mg figures themselves are in the complete mg guide, and the ranked products are in the master ranking.
What nobody has measured
This field is thinner than its confident internet coverage suggests. A targeted search of the published literature for oral nicotine products rated for harshness, burning, tingling or oral irritation returns nine records in total. Specifically missing:
- A nicotine dose-response in pouches with formulation physically held constant. Nobody has made matched pouches differing only in nicotine. The Han study adjusts for flavour statistically across twenty commercial products; that is not the same experiment.
- An adequately powered test of burn against plasma nicotine. The two studies that found no relationship had fifteen and twenty participants. “No detectable relationship in small studies” is not “independent”.
- Any placement comparison. Every clinical study I read put the pouch between the upper lip and gum. Nobody has tested whether site changes either sensation.
- Any experimental manipulation of pouch moisture. The closest thing in print is a sponsor’s discussion section calling for it.
- Burn measurements in the industry’s own dose-ranging work. I searched the full text of a 1.5–8 mg pharmacokinetic study from on!’s manufacturer: zero occurrences of irritation, burning, harshness or tingling. A clean nicotine gradient in real people, and nobody asked the question.
Frequently asked questions
If a pouch doesn’t sting, am I getting less nicotine? No. The clearest counter-example in the literature is a cigarette: more nicotine in the blood than a 20 mg pouch and the lowest irritation of anything tested in the same session. Within pouches, a stronger product rates slightly harsher on average, but the overlap is enormous.
Does a stronger pouch always burn more? On average, slightly. The measured effect is about seven points of harshness on a hundred-point scale for roughly double the nicotine, and the flavour of the pouch moved burn by twelve points in another study. Flavour choice is a bigger lever than strength.
Why does the first pouch of the day sting most? Nicotine desensitises the tissue to its own irritation within about thirty minutes, and the effect is still measurable at 24 hours before disappearing by 48. No change in your nicotine sensitivity is needed to explain it.
Is the burning dangerous? That is not a question this page can answer, and I would not try. The one clinical study that inspected mouths found slight redness in a minority of participants after twenty minutes of use and one ulceration, in a group of fifteen. If something in your mouth is not settling, that is a question for a dentist or doctor, not a website.
Can I find out how much coolant is in my pouch? No. No manufacturer publishes a coolant quantity for any product. Every figure on this page came from an academic laboratory buying pouches and running them through a mass spectrometer.
What should I actually change if the sting bothers me? Switch flavour family before switching strength — fruit rated twelve points lower on burning than mint at comparable nicotine — and if you want to keep your dose while doing it, hold time is the documented lever.
Sources
- Peraza N, Han DH, Whaley RC, et al. “Appeal and Sensory Characteristics of Oral Nicotine Products in Young Adults Who Vape E-Cigarettes.” Nicotine & Tobacco Research 2026;28(2):204–212. PMID 39607696. Funded by NCI, FDA CTP, NIDA and NHLBI; competing interests “None declared.”
- Han DH, Martines C, Duran M, et al. “Effects of nicotine concentration and pH on nicotine pouch appeal and sensory experience: A randomized experimental study.” Addiction 2026. PMID 42159066; full text PMC13220287. FDA and NIDA funded; one author discloses pharmaceutical-industry relationships outside the work.
- Mallock-Ohnesorg N, Rabenstein A, Stoll Y, et al. “Small pouches, but high nicotine doses—nicotine delivery and acute effects after use of tobacco-free nicotine pouches.” Frontiers in Pharmacology 2024. PMC11150668. Funded by the German Federal Institute for Risk Assessment; no commercial relationships declared. Trial registration DRKS00026244.
- Talavera K, Gees M, Karashima Y, et al. “Nicotine activates the chemosensory cation channel TRPA1.” Nature Neuroscience 2009. PMID 19749751.
- Kichko TI, Neuhuber W, Kobal G, Reeh PW. “The roles of TRPV1, TRPA1 and TRPM8 channels in chemical and thermal sensitivity of the mouse oral mucosa.” European Journal of Neuroscience 2018. PMID 29247491.
- Dessirier JM, O’Mahony M, Carstens E. “Time course of self-desensitization of oral irritation by nicotine and capsaicin.” Chemical Senses 2008. PMID 17641107. NIDCR grant DE13685.
- Jabba SV, et al. “Pre- and post-flavour-ban nicotine pouch products: synthetic coolant content and sensory characteristics.” Tobacco Control 2026; author manuscript PMC13454924. NIH and FDA funded; one author discloses consultancy for the California Department of Justice and FDA advisory-committee service.
- Jabba SV, et al. on sweetener content in oral nicotine products. Nicotine & Tobacco Research 2026;28(2):223–229. PMID 39656927. NIH/FDA funded; no financial disclosures reported.
- Hardie G, et al. “A Randomized Crossover Clinical Study to Assess the Effect of Oral Nicotine Pouches Used for Different Durations on Plasma Nicotine Pharmacokinetics.” Journal of Clinical Pharmacology 2025. PMID 40781988. Sponsored and funded by British American Tobacco; all authors were BAT employees at the time.
- Rosbrook K, Green BG, et al. “Impacts of Nicotine and Flavoring on the Sensory Perception of E-Cigarette Aerosol.” Nicotine & Tobacco Research 2020. PMID 30997500. NCI grant P50 CA180523.
- Mallock N, et al. on nicotine pouch pharmacokinetics in on! products. Psychopharmacology 2022. PMC9385814. Authors are employees of Altria Client Services LLC.
- Study of inhaled nicotine salt and free-base pharmacokinetics and subjective effects, Nicotine & Tobacco Research 2024. PMID 38597729. Multiple author disclosures including a spouse employed by Philip Morris International.
Every quotation on this page was checked character by character against the publisher’s or database’s own copy of the document on 2 November 2026. Where a figure is my own arithmetic rather than a published number, I have said so.
